A~(18)F-fluorodeoxyglucose (FDG)/PET Study of Advanced Parkinson's Disease
Chuantao Zuo
2003-01-01
Abstract:Objective To study regional cerebral glucose utilization with 18F-fluorodeoxyglucose (FDG)/PET in advanced Parkinson's disease (PD), and investigate the imaging characteristics of advanced PD patients.Methods Eight advanced Parkinson's diseases patients (5 men, 3 women; mean age 63.5±3.7;mean H-Y disability scale 4.1±0.5) and 8 age-matched healthy subjects underwent 18F-FDG/PET examinations at resting-state . Statistical parametric mapping (SPM) was usedto investigate regional cerebral metabolic rate of glucose (rCMRGlu). Results Compared to age-matched healthy subjects, the regional glucose metabolism increased in both thalamus, precentral cortex(BA6) and lentiform and decreased in both prefrontal motor area (BA46), parietal-occipital area as defined in the atlas of Talairach and Tournoux (P0.001)in advanced PD cases.Conclusions Hypermetabolism in thalamus and lentiform accompany with hypometabolism in prefrontal motor area and parietal-occipital cortex can be found in advanced PD patients, and this special regional cerebral metabolism pattern is helpful to diagnosis and investigates the pathophysiology of PD.
What problem does this paper attempt to address?